| Issue |
Section |
Title |
File |
| Vol 78, No 12 (2003) |
Editorial |
Diagnostic and prognostic significance of D-dimer in internal medicine |
|
| Vol 79, No 12 (2004) |
Editorial |
Low-molecular heparins in the treatment of non-iT elevation acute coronary syndrome |
|
| Vol 80, No 7 (2008) |
Editorial |
Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis |
|
| Vol 81, No 9 (2009) |
Editorial |
Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment |
|
| Vol 82, No 8 (2010) |
Editorial |
Risk factors for venous thromboembolic events and their association with D-dimer level |
|
| Vol 83, No 3 (2011) |
Editorial |
Genetic polymorphisms coding hemostasis protein synthesis and venous thromboembolic complications in Moscow population |
|
| Vol 83, No 6 (2011) |
Editorial |
Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage |
|
| Vol 83, No 8 (2011) |
Editorial |
Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins |
|
| Vol 83, No 12 (2011) |
Editorial |
Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications |
|
| Vol 89, No 9 (2017) |
Editorial |
Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up |
(Rus)
|
| Vol 90, No 9 (2018) |
Editorial |
Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions |
(Rus)
|
| Vol 91, No 9 (2019) |
Editorial |
Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention |
(Rus)
|
